NL-OMON24060已完成不适用
Validation of simplified quantitative [18F]FLT PET methods in NSCLC patients treated with gefitinib.
VU University Medical Center (VUmc) Amsterdam0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
/A
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patient age 18 years or older;
- •2. Histological diagnosis of NSCLC;
排除标准
- •1. Pregnant or lactating patients;
- •2. Metal implants (e.g. pacemakers);
研究者
相似试验
已完成
2 期
Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic AdenocarcinomaPancreatic AdenocarcinomaNCT03318497University of Texas Southwestern Medical Center6
已完成
不适用
A pilot study for effective evaluations of FLT-PET in the effect of stereotactic radiotherapy on non-small-cell lung cancerJPRN-UMIN000016489Foundation of Biomedical Research and Innovation2
撤回
2 期
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment EvaluationHead and Neck CancerNCT00894101University of California, Irvine
已完成
1 期
Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate CancerProstate CancerNCT03793543Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins23
进行中（未招募）
1 期
Detección de metástasis del cáncer de próstataPacientes varones después de un primer diagnóstico de cáncer de próstata basado en estudio histopatológico (biopsia mediante punción del tumor primario)De novo patients with histologically confirmed prostate cancerMedDRA version: 14.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-014839-21-ESCIS bio international, member of IBA group150